• 

  Want a Diet That Reduces Dementia Risk? Diversify
• 

  Phil’s Journal: Waiting While Approval for Biogen’s Alzheimer’s Drug is Delayed, Yet Again
• 

  Will COVID-19 Cause Lifelong Neuropsychiatric Conditions?
• 

  Study: Mild Behavioral Impairment Can Help Predict Alzheimer’s
• 

  New Genetic Variant Discovered to Protect Against Risk of Alzheimer’s Gene ApoE4
• 

  Largest Alzheimer’s Study on Protein Networks Reveals Possible New Biomarker
• 

  Jason Karlawish: What is ‘ICU Delirium,’ and What Can Dementia Caregivers Do About It?
• 

  Phil’s Journal: How Caregivers Help People With Dementia Avoid Developing Delirium in the Hospital
• 

  Researchers Conduct First Human Trial For Drug Aiming to Treat Traumatic Brain Injury
• 

  Scientists Develop Safer, More Efficient Brain Implants to Help Monitor Parkinson’s and Other Diseases
• 

  Reframing the Crisis with Dr. Steven Sabat: How Caregivers Can Manage Mental Health During COVID-19
• 

  ‘A4’ Study Aims Targets Amyloid in Alzheimer’s Earliest Stages
• 

  Words Matter: Choosing Words Wisely When It Comes to Alzheimer’s and Coronavirus
• 

  Lori Nisson: How to Create a Caregiving Plan for COVID-19
• 

  Exercise Four Times a Day Reduces Neuropsychiatric Symptoms in People With Dementia

Previous100101102Next